We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




POC Metabolic Panel for Oncology

By HospiMedica staff writers
Posted on 24 Aug 2005
A new basic metabolic panel is a point-of-care (POC) test designed to help oncologists and hematologists determine the fitness of cancer patients for chemotherapy while the patient is on site.

The Piccolo panel generates accurate results in minutes, providing information on calcium, chloride, creatinine, glucose, potassium, sodium, total carbon dioxide, urea nitrogen, magnesium, and lactate dehydrogenase.

"The test panel was developed specifically on direct feedback from oncology practices seeking a more specific treatment assessment tool,” noted Clint Severson, chairman and CEO of Abaxis, Inc. More...
(Union City, CA, USA), which developed the panel. "We can now give our oncology customers complete diagnostic capabilities to monitor their patients' health immediately prior to treatment.”

Abaxis develops, manufactures, and markets portable blood analysis systems to provide clinicians with rapid blood constituent measurements. The system includes a portable analyzer plus a series of single-use reagent discs. Whole blood, serum, or plasma may be tested with the system, and results are available in less then 14 minutes.

"Sending any tests to an outside laboratory is no longer necessary. We are providing oncologists with all the information they need to make effective treatment decisions for their patients in just minutes,” added Ron Blasig, director of marketing for Abaxis.




Related Links:
Abaxis

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.